Related Experiment Video
Updated: Jun 11, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out
Andreas Michael Schmitt1, James Larkin2, Sapna P Patel3
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Abstract:
This comment discusses the use of PD-L1 as a biomarker to guide treatment decisions for metastatic melanoma.
More Related Videos
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Tumor Immunotherapy
The Intrinsic Apoptotic Pathway
Abnormal Proliferation